The Relation of Postmenopausal Hormone Therapy to Serum Uric Acid and the Risk of Coronary Heart Disease Events: The Heart and Estrogen–Progestin Replacement Study (HERS)
- 21 July 2005
- journal article
- research article
- Published by Elsevier in Annals of Epidemiology
- Vol. 16 (2) , 138-145
- https://doi.org/10.1016/j.annepidem.2005.04.003
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Risk Factors for Coronary Artery Disease in Healthy Persons with Hyperinsulinemia and Normal Glucose ToleranceNew England Journal of Medicine, 1989
- Aspirin, Sulfinpyrazone, or Both in Unstable AnginaNew England Journal of Medicine, 1985
- The Anturane Reinfarction Trial: Reevaluation of OutcomeNew England Journal of Medicine, 1982
- The FDA's Critique of the Anturane Reinfarction TrialNew England Journal of Medicine, 1980
- Sulfinpyrazone in the Prevention of Sudden Death after Myocardial InfarctionNew England Journal of Medicine, 1980
- Uric acid: a risk factor for coronary heart disease?Circulation, 1979
- Sulfinpyrazone in the Prevention of Cardiac Death after Myocardial InfarctionNew England Journal of Medicine, 1978
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976
- Hyperuricemia in coronary, cerebral and peripheral arterial disease: An explanationMedical Hypotheses, 1975